New Born Screening Working Group Expert @ EURORDIS
Head of Outreach and Healthcare Partnerships Development - Rare Diseases @ CheckOrphan, Medical-Scientific Communications
Director Portfolio Management - Immune-Oncology, Immunology-Inflammatory, Oncology, Ophthalmology @ Fresenius Kabi
Market and Analytics, Biopharma Business and Development Decision Support @ Strategy & Management Consulting
Director Business Development and Strategic Alliances, Commercial Operations @ Amneal Pharmaceuticals GmbH, International HQs of Amneal LLC (USA)
Director Business Development and Licensing @ AZAD Pharma AG, spin-off from Johnson & Johnson
Director Out Licensing @ AZAD Pharma AG, spin-off from Johnson & Johnson
Dorota Zgodka's Education
London Business School
Executive Education, Finance, General
University of Iowa
Postdoctoral Fellowship (Drug Discovery, antiviral new drug candidates against HIV and other herpes viruses)
Gdańsk University of Technology
Post Graduate, Economy and Marketing Department (Business Management)
Gdańsk University of Technology
Ph.D., D.Sc., Biomedical Science, Drug Discovery; M.Sc., Eng. Biotechnology
Dorota Zgodka's Skills
Out-licensing
Pharmaceutical Industry
Generic Programming
Business Development
Market Access
Pharmaceutical Sales
Technology Transfer
Biotechnology
Oncology
Regulatory Affairs
Dorota Zgodka's Summary
Dorota Zgodka, based in Zürich, ZH, CH, is currently a Healthcare Principal and Head of Business Development, Chief of Staff - Common and Rare Diseases at Experientia, bringing experience from previous roles at Health Technology Assessment international (HTAi), FH Europe - The European FH Patient Network, EURORDIS and CheckOrphan, Medical-Scientific Communications. Dorota Zgodka holds a Executive Education, Finance, General @ London Business School. With a robust skill set that includes Out-licensing, Pharmaceutical Industry, Generic Programming, Business Development, Market Access and more, Dorota Zgodka contributes valuable insights to the industry. Dorota Zgodka has 2 emails on RocketReach.